SPRB - Spruce Biosciences, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
170.27 -6.35 (-3.73%) --- --- --- 1.75 (1.03%) -12.32 (-7.18%) 1.92 (1.19%) 1.92 (1.19%)

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.32
Diluted EPS:
-0.32
Basic P/E:
-512.25
Diluted P/E:
-512.25
RSI(14) 1m:
100.0
VWAP:
163.36
RVol:

Events

Period Kind Movement Occurred At

Related News